Mark Hancock reports multiple PACS share sales
Mark Hancock reported multiple sales of Common stock of PACS via Form 144, listing specific transactions between 06/15/2026 and 07/08/2026.
Rhea-AI Filing Summary
Mark Hancock reported multiple sales of Common stock of PACS via Form 144, listing specific transactions between 06/15/2026 and 07/08/2026. The filing lists individual trades with share counts and gross proceeds, including notable sales of 153,254 shares for $5,568,759.95 and 142,163 shares for $6,444,860.09.
The notice names Citigroup Global Markets Inc. as the broker and records multiple cash sales on discrete dates. The filing is a resale disclosure of transactions by a single holder; cash‑flow treatment and any post‑transaction holdings are not stated in the provided excerpt.
Positive
- None.
Negative
- None.
Insights
Multiple open‑market dispositions by a single holder across June–July 2026.
The excerpt lists discrete sales by Mark Hancock executed through Citigroup Global Markets Inc., with per‑trade shares and gross proceeds recorded on specific dates such as 06/15/2026 and 07/06/2026. The filing functions as a resale notice and records cash sales.
Materiality depends on post‑transaction holdings and percentage of outstanding shares, which the excerpt does not state. Subsequent filings may disclose remaining beneficial ownership or confirm whether the sales were under a trading plan.
Key Figures
Key Terms
Form 144 regulatory
resale financial
gross proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What sales did Mark Hancock report in the PACS Form 144?
Which broker handled the reported PACS transactions?
Does the Form 144 show the purpose or purchaser for these PACS sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.